Issam Raad Selected Research

Central Venous Catheters

1/2018	Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections.
1/2018	Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients.
10/2017	Comparing catheter-related bloodstream infections in pediatric and adult cancer patients.
3/2017	Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center.
1/2017	Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients".
1/2017	A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.
1/2016	A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.
1/2016	Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.
1/2015	Biofilm-based central line-associated bloodstream infections.
9/2014	The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Issam Raad Research Topics

Disease

58	Neoplasms (Cancer) 01/2022 - 01/2002
50	Infections 01/2022 - 01/2002
46	Sepsis (Septicemia) 12/2021 - 01/2002
29	Bacteremia 01/2019 - 01/2002
14	Neutropenia 06/2022 - 02/2002
9	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 05/2004
9	Mycoses (Diseases, Fungus) 12/2017 - 01/2003
8	Fever (Fevers) 06/2022 - 01/2003
6	Aspergillosis 01/2022 - 12/2004
5	Bacterial Infections (Bacterial Infection) 12/2021 - 05/2007
5	Critical Illness (Critically Ill) 01/2015 - 01/2004
4	Candidemia 01/2021 - 04/2004
4	Leukemia 09/2019 - 03/2003
4	Catheter-Related Infections 01/2017 - 02/2002
3	Invasive Pulmonary Aspergillosis 12/2018 - 04/2006
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017 - 01/2003
2	Febrile Neutropenia 06/2022 - 12/2021
2	Invasive Fungal Infections 01/2022 - 01/2003
2	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2014
2	Hypersensitivity (Allergy) 09/2019 - 08/2004
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 12/2009
2	Lung Neoplasms (Lung Cancer) 12/2018 - 11/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2015
2	Communicable Diseases (Infectious Diseases) 01/2016 - 01/2004
2	Inflammation (Inflammations) 05/2014 - 11/2013
2	Arthralgia (Joint Pain) 06/2004 - 04/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2004 - 01/2003
1	Mucormycosis 01/2022
1	Hallucinations (Hallucination) 01/2021
1	Nausea 01/2021
1	Vomiting 01/2021
1	Lung Diseases (Lung Disease) 12/2018
1	Pyelonephritis 01/2017

Drug/Important Bio-Agent (IBA)

21	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 02/2002
12	Vancomycin FDA LinkGeneric 01/2019 - 02/2002
11	ProcalcitoninIBA 12/2021 - 12/2012
10	Minocycline (Cyclops)FDA LinkGeneric 01/2016 - 02/2002
8	SolutionsIBA 01/2017 - 02/2002
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2013
7	Edetic Acid (EDTA)FDA Link 01/2019 - 02/2002
6	posaconazole FDA Link 01/2021 - 01/2007
6	Voriconazole (Vfend)FDA LinkGeneric 01/2021 - 01/2007
6	CoagulaseIBA 01/2019 - 10/2009
5	Linezolid (Zyvox)FDA Link 07/2018 - 07/2003
5	Rifampin (Rifampicin)FDA LinkGeneric 09/2014 - 10/2003
4	Fluconazole (Zonal)FDA LinkGeneric 01/2021 - 01/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 04/2004
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017 - 11/2013
4	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 02/2002
3	Anti-Infective Agents (Microbicides)IBA 06/2022 - 02/2010
3	AzolesIBA 01/2022 - 01/2011
3	Daptomycin FDA Link 01/2019 - 08/2010
3	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2017 - 01/2016
3	Ethanol (Ethyl Alcohol)IBA 01/2016 - 01/2007
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2021 - 08/2021
2	C-Reactive ProteinIBA 08/2021 - 12/2014
2	Alkaline PhosphataseIBA 01/2021 - 06/2004
2	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 01/2014
2	Pregnenolone Carbonitrile (PCN)IBA 09/2019 - 01/2017
2	Ceftaroline FDA Link 01/2019 - 04/2017
2	Citric Acid (Citrate)FDA LinkGeneric 01/2019 - 01/2016
2	SuspensionsIBA 03/2016 - 01/2007
2	TabletsIBA 03/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2013
2	AdrenomedullinIBA 04/2013 - 01/2013
2	ChlorhexidineIBA 02/2012 - 02/2007
2	SteroidsIBA 01/2011 - 01/2003
2	Local Anti-Infective Agents (Antiseptics)IBA 12/2009 - 05/2007
2	liposomal amphotericin B FDA Link 05/2006 - 01/2003
2	SiliconesIBA 08/2004 - 02/2002
2	quinupristin-dalfopristin (Synercid)FDA Link 06/2004 - 04/2004
2	Itraconazole (Sporanox)FDA LinkGeneric 02/2004 - 01/2003
1	Cephalosporins (Cephalosporin Antibiotics)IBA 06/2022
1	tazobactam drug combination ceftolozaneIBA 06/2022
1	isavuconazoleIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	CefiderocolIBA 01/2020
1	Penicillins (Penicillin)FDA Link 09/2019
1	Chelating AgentsIBA 01/2019
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 12/2018
1	galactomannanIBA 12/2018
1	Tigecycline (Tygacil)FDA Link 04/2017
1	Sulfamethoxazole FDA LinkGeneric 04/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 04/2017

Therapy/Procedure

48	Catheters 01/2019 - 01/2002
36	Therapeutics 01/2022 - 01/2002
25	Central Venous Catheters 01/2018 - 01/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2004
4	Duration of Therapy 01/2021 - 01/2018
3	Length of Stay 12/2021 - 02/2005
3	Renal Dialysis (Hemodialysis) 01/2019 - 10/2003
3	Vascular Access Devices (Arterial Line) 10/2007 - 10/2003
2	Stem Cell Transplantation 12/2018 - 03/2003
2	Critical Care (Surgical Intensive Care) 10/2013 - 01/2011
2	Hematopoietic Stem Cell Transplantation 01/2007 - 10/2006
2	Induction Chemotherapy 02/2004 - 01/2003
1	Radiotherapy 12/2018